Cite

HARVARD Citation

    Seymour, J. et al. (n.d.). Bone marrow hypocellularity does not affect tolerance or efficacy of azacitidine in patients with higher‐risk myelodysplastic syndromes. British journal of haematology. pp. 49-56. [Online]. 
  
Back to record